Trial · NCT02865720
Results by group98
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 98
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | CINRYZE 1000 U | 7 | Participants | ||
| Number of Participants With Clinically Significant Abnormalities in Physical Examination Reported as Adverse Events (AEs) | CINRYZE 1000 U | 0 | Participants | ||
| Number of Participants With Potentially Clinically Important (PCI) Vital Signs Reported as Adverse Events (AEs) | CINRYZE 1000 U | 0 | Participants | ||
| Number of Participants With Potentially Clinically Important (PCI) Clinical Laboratory Assessments Reported as Adverse Events (AEs) | CINRYZE 1000 U | 0 | Participants | ||
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 1 | CINRYZE 1000U | Pre-dose | 0.0581 | Standard Deviation 0.04877 | Gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 1 | CINRYZE 1000U | 0.5 h post-dose | 0.1463 | Standard Deviation 0.04210 | Gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 1 | CINRYZE 1000U | 1 h post-dose | 0.1426 | Standard Deviation 0.05795 | Gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 1 | CINRYZE 1000U | 2 h post-dose | 0.1436 | Standard Deviation 0.04524 | Gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 1 | CINRYZE 1000U | 6 h post-dose | 0.1413 | Standard Deviation 0.04376 | Gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 1 | CINRYZE 1000U | 24 h post-dose | 0.1147 | Standard Deviation 0.03825 | Gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 1 | CINRYZE 1000U | 48 h post-dose | 0.0978 | Standard Deviation 0.04204 | Gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 1 | CINRYZE 1000U | 72 h post-dose | 0.0881 | Standard Deviation 0.04133 | Gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 1 | CINRYZE 1000U | 96 h post-dose | 0.0680 | Standard Deviation NA | Gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 12 | CINRYZE 1000 U | Pre-dose | 0.0775 | Standard Deviation 0.04904 | gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 12 | CINRYZE 1000 U | 0.5 h post-dose | 0.1660 | Standard Deviation 0.04159 | gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 12 | CINRYZE 1000 U | 1 h post-dose | 0.1468 | Standard Deviation 0.03232 | gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 12 | CINRYZE 1000 U | 2 h post-dose | 0.1634 | Standard Deviation 0.04500 | gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 12 | CINRYZE 1000 U | 6 h post-dose | 0.1573 | Standard Deviation 0.03978 | gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 12 | CINRYZE 1000 U | 24 h post-dose | 0.1244 | Standard Deviation 0.04675 | gram per liter (g/L) |
| Concentration of C1 Esterase Inhibitor (C1 INH) Antigen (Protein Volume) at Week 12 | CINRYZE 1000 U | 48 h post-dose | 0.1003 | Standard Deviation 0.05030 | gram per liter (g/L) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02865720/results